Heres how it works, step by step: Initial Consultation: Your journey begins with a comprehensive consultation with Dr
At Salenger, Sack, Kimmel & Bavaro, LLP, we are currently reviewing national claims involving these weight loss and diabetes drugs, which are linked to stomach paralysis and long-term gastrointestinal injuries
Many patients continue tirzepatide at a reduced dose to maintain their weight loss
The Bridge exists because federal law has historically prohibited Medicare from covering drugs used solely for weight loss
Sources Food and Drug Administration (FDA): FDA Approves New Medication for Chronic Weight Management Molecular Metabolism Journal: Glucagon-like peptide 1 (GLP-1) American Gastroenterological Association (AGA): Biology of Incretins: GLP-1 and GIP Columbia Surgery: The Ozempic Effect: Everything You Need to Know About Medical Weight Loss Eli Lilly: Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies American Diabetes Association (ADA): Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes Important Medical Information and Disclaimers Important Current Status Update : As of March 19, 2025, the FDA has ended enforcement discretion for compounded tirzepatide
